Cutting-Edge HIV PrEP
Cutting-Edge Concepts in HIV Care: PrEP

Released: November 14, 2022

Expiration: November 13, 2023

Activity

Progress
1
Course Completed

In this episode, Paul E. Sax, MD, discusses the latest recommendations and options for HIV pre-exposure prophylaxis (PrEP), including:

  • CDC PrEP guideline 2021 updates for oral PrEP
  • The ANRS IPERGAY study: on-demand oral emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) PrEP in men who have sex with men who are at high risk for HIV infection
  • A review of the HPTN 083 and 084 studies: efficacy and safety of long-acting (LA) injectable cabotegravir (CAB) vs daily oral FTC/TDF for PrEP
  • 1-year follow-up after unblinding for HPTN 083 and 084
  • LA CAB for PrEP: monitoring and safety
  • Stopping LA CAB for PrEP